Meadow Creek Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $266K | Sell |
7,260
-66
| -0.9% | -$2.42K | 0.01% | 935 |
|
|
2019
Q2 | $341K | Sell |
7,326
-1,914
| -21% | -$89.1K | 0.01% | 849 |
|
|
2019
Q1 | $371K | Buy |
9,240
+286
| +3% | +$11.5K | 0.01% | 799 |
|
|
2018
Q4 | $412K | Sell |
8,954
-1,826
| -17% | -$84K | 0.01% | 704 |
|
|
2018
Q3 | $478K | Buy |
10,780
+9,350
| +654% | +$415K | 0.01% | 744 |
|
|
2018
Q2 | $56K | Sell |
1,430
-12,452
| -90% | -$488K | ﹤0.01% | 1247 |
|
|
2018
Q1 | $1M | Buy |
13,882
+10,516
| +312% | +$761K | 0.02% | 427 |
|
|
2017
Q4 | $222K | Sell |
3,366
-2,442
| -42% | -$161K | ﹤0.01% | 960 |
|
|
2017
Q3 | $291K | Sell |
5,808
-704
| -11% | -$35.3K | 0.01% | 792 |
|
|
2017
Q2 | $301K | Sell |
6,512
-2,200
| -25% | -$102K | 0.01% | 728 |
|
|
2017
Q1 | $308K | Hold |
8,712
| – | – | 0.01% | 654 |
|
|
2016
Q4 | $109K | Buy |
+8,712
| New | +$109K | ﹤0.01% | 899 |
|